Healthcare Capital Acquisition (HCAC) Stock Price, News & Analysis

Company Overview

Healthcare Capital Acquisition (NASDAQ: HCAC) is a special purpose acquisition company (SPAC), commonly referred to as a blank‑check company, formed to raise capital through a public listing and pursue one or more business combinations. As a SPAC, Healthcare Capital Acquisition does not operate commercial businesses of its own; instead it holds funds in trust while identifying and negotiating a merger, acquisition or other business combination with an operating company, with a stated focus on opportunities in the healthcare sector.

The firm’s primary activities include sourcing and evaluating potential targets in healthcare and life sciences, structuring transactions, and completing a business combination that would result in the target becoming a publicly listed company. Typical target areas for healthcare‑focused SPACs include biopharmaceuticals, medical device and diagnostics companies, healthcare services and technology platforms. Until a transaction is completed, the company’s principal “product” is access to capital and a public listing that can be used to facilitate growth or liquidity for private healthcare businesses.

Public filings and offering documents provide the most reliable detail about the company’s sponsors, board and executive team, transaction criteria and timelines; interested investors should review those materials for up‑to‑date information. Like other SPACs, Healthcare Capital Acquisition operates under a finite period to complete a business combination and may pursue targets in the U.S. and internationally depending on strategic fit. Because the company’s activities are transaction‑oriented, the nature of its operations and the markets it serves will be defined largely by the business it ultimately combines with.

Key Stats

• Today's Range: $9.97 to $9.97
• 50-Day Range: $9.92 to $10.02
• 52-Week Range: $9.91 to $10.06
• Volume: 22,067 shs
• Average Volume: 124,278 shs
• Market Capitalization: $371.95 million
• P/E Ratio: 199.40
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HCAC Stock Analysis - Frequently Asked Questions

How have HCAC shares performed this year?

Healthcare Capital Acquisition's stock was trading at $10.00 at the start of the year. Since then, HCAC shares have decreased by 0.3% and is now trading at $9.97.

When does the company's lock-up period expire?

Healthcare Capital Acquisition's lock-up period expires on Wednesday, May 20th. Healthcare Capital Acquisition had issued 18,000,000 shares in its public offering on November 21st. The total size of the offering was $180,000,000 based on an initial share price of $10.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of Healthcare Capital Acquisition?

Shares of HCAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Healthcare Capital Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Healthcare Capital Acquisition investors own include Workhorse Group (WKHS), FuelCell Energy (FCEL), Plug Power (PLUG), Fortress Biotech (FBIO), Lipocine (LPCN), Ovid Therapeutics (OVID) and Alamos Gold (AGI).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HCAC
• CIK: 2079013
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 199.40
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 37,307,000
• Free Float: N/A
• Market Cap: $371.95 million
• Optionable: N/A
• Beta: 0.41